Get the Daily Brief
Latest Biotech News
Bristol Myers Squibb Expands Radiopharmaceutical Portfolio
Bristol Myers Squibb, through its RayzeBio subsidiary, acquired global rights to Philochem AG’s OncoACP3, a radiopharmaceutical candidate for prostate cancer, with a $350 million upfront payment...
SpliceBio Closes $135 Million Series B to Advance Gene Therapy
SpliceBio secured $135 million in Series B funding to support clinical development of its lead gene therapy candidate, SB-007, for Stargardt disease. The dual AAV vector therapy aims to deliver...
Novel CRISPR-Cas13 RNA Editing Advances Therapeutics
Researchers have advanced RNA-targeting CRISPR-Cas13 technology to enable selective modification of desired RNA sequences in living cells. This next-generation gene therapy approach shows promise...
Innovative AI Accelerates Drug Discovery: Insilico Medicine Launch
Insilico Medicine launched Nach01, a multimodal foundation AI model on AWS Marketplace designed to accelerate generative chemistry for drug design. This large language model integrated with...
Breakthrough in Precision Gene Editing via Autophagy Induction
A Korean research team demonstrated that inducing autophagy significantly enhances homologous recombination efficiency during CRISPR-Cas9 genome editing. By shifting DNA repair pathways towards...
Robotic Innovations Enable Precision Agriculture Technologies
Cornell University researchers developed a soft robotic gripper capable of gently injecting sensors and genetic material into living plant leaves. This technology facilitates precise monitoring...
FDA Accelerates Gene Therapy Pathway with Sarepta Designation
The FDA has granted Sarepta Therapeutics a platform technology designation to streamline regulatory review for its gene therapy candidates, especially those targeting rare diseases. This status is...
Breakthroughs in Cancer Therapeutics and Diagnostics
Advances in cancer treatment continue with innovative clinical and preclinical studies. Saga Diagnostics launched a tumor-informed molecular residual disease test for early-stage breast cancer,...
Innovations in RNA and Genetic Editing Therapeutics
Research reveals significant progress in RNA-based therapeutics and precision gene editing. Korro Bio focuses on RNA editing technology offering reversible, precise modifications to address...
AI and Digital Technologies Propel Biotech Drug Discovery
Artificial intelligence integration intensifies within biotech, transforming drug development. Sofinnova partners with NVIDIA to gain AI capabilities enhancing portfolio analytics and discovery....
New Frontiers in Oncology: Immunotherapy and Tumor Microenvironment
Immunotherapy strategies advance with Cabaletta Bio reporting CAR-T treatment efficacy in autoimmune conditions, planning pivotal trials. Albatroz pursues novel tumor metastasis prevention via...
AI-Enhanced Agriculture and Environmental Monitoring
Emerging technologies redefine agricultural practices and environmental conservation. University of Florida employs digital twins combined with AI to simulate strawberry farming for year-round...
Emerging Diagnostic and Therapeutic Technologies in Neurology and Metabolism
Neurological and metabolic research makes pivotal strides. Harvard SEAS engineers devised soft bioelectronic implants to monitor developing tadpole brains, enabling unprecedented neural circuit...
Pandemic Response, Vaccine Policy, and Public Health Controversies
Vaccine advisory dynamics in the U.S. face upheaval as Health Secretary RFK Jr. removed all 17 members of CDC’s Advisory Committee on Immunization Practices, sparking criticism and calls for...
Novel Material Sciences and Optical Technologies Push Scientific Boundaries
Material and optical sciences report significant innovations. Researchers developed a high strength eutectic multi-principal element alloy via powder bed fusion laser beam offering promising...
HHS Secretary’s Removal of CDC Vaccine Panel Sparks Uproar
Health and Human Services Secretary Robert F. Kennedy Jr.'s abrupt dismissal of all 17 CDC Advisory Committee on Immunization Practices members has drawn sharp criticism from medical and public...
FDA Grants Sarepta Platform Status to Speed Gene Therapy Reviews
The FDA’s new platform technology designation awarded to Sarepta Therapeutics signals enhanced regulatory support for pioneering gene therapies. Sarepta’s RNA editing platform stands poised to...
FDA Grants Sarepta Platform Status to Speed Gene Therapy Reviews
Sarepta Therapeutics has secured a platform technology designation from the FDA, signaling a regulatory shift to accelerate review processes for gene therapy applications targeting rare diseases....
NIH Scientists Protest Politicization of Research Funding
Over 300 NIH employees issued a letter condemning politicized funding and staffing cuts undermining scientific research, highlighting grant cancellations, hiring freezes, and international...
Eli Lilly Commits $650M to AI-Driven Muscle Health Research
Eli Lilly's $650 million deal with Juvena Therapeutics focuses on using AI-enabled screening platforms to identify novel candidates boosting muscle health and regeneration, aiming to complement...